Gallbladder Diseases (Gall Bladder Disease)

05/01/1980 - "It is concluded that in some individuals with continuing symptoms suggesting gallbladder disease but normal oral cholecystograms, cholecystokinin cholecystography may be helpful in identifying physiologic dysfunction of the gallbladder."
01/01/1992 - "The physiologic studies on gallbladder contraction and cholecystokinin release in a subset of the patients failed to provide information on a mechanism for the possible increased incidence of gallbladder disease."
09/01/1985 - "The objective of this study was to examine the effect of aging on gallbladder contraction and cholecystokinin (CCK) release, as well as on the correlation between the two in humans who are free of gallbladder disease. "
02/01/2010 - "Calculation of a gallbladder ejection fraction after cholecystokinin infusion is commonly used to diagnose chronic acalculous gallbladder disease. "
07/01/2003 - "Acalcolous gallbladder disease is the clinical setting deserving further investigation on the value of the cholecystokinin provocative test, but this test needs to be standardized."

08/15/1987 - "These results, which need to be confirmed by further studies, show that in acalculous gallbladder disease there is a delay in gallbladder emptying which could explain the formation of cholesterol crystals by bile stasis as described by various authors."
08/01/1932 - "STUDIES IN CHOLESTEROL METABOLISM : 3. Cholesterol and Gall Bladder Disease."
02/01/2013 - "These findings suggest that aberrant expression and/or function of ABC sterol transporters may be associated with cholesterol-related gallbladder diseases (CAGD). "
10/01/2008 - "The quantity of cholesterol was significantly less in the GS of GBC than in benign gallbladder diseases (CC or XGC, P < 0.0001 for both). "
04/01/2003 - "Cholesterol crystal morphology in acalculous gallbladder disease."

11/01/2004 - "Five human studies investigated the safety and efficacy of sincalide in patients with PN-associated gallbladder disease. "
04/01/2006 - "For chronic acalculous gallbladder disease, calculation of a gallbladder ejection fraction during sincalide cholescintigraphy can confirm the clinical diagnosis and has become a common routine procedure in many nuclear medicine clinics. "
06/01/1996 - "Findings of hepatobiliary scintigraphy with intravenous cholecystokinin octapeptide (sincalide) were examined in 26 asymptomatic patients with various malignancies but no known pre-existing gallbladder disease, and normal hepatobiliary and gallbladder morphology on sonography. "
09/01/1986 - "These findings suggest that the ability of CCK-8 to maintain high bile flows during TPN may have prophylactic relevance for prevention of TPN-induced gallbladder disease. "
06/01/1985 - "The role of sincalide cholescintigraphy in the evaluation of patients with acalculus gallbladder disease."

05/01/2010 - "Even though elderly patients are more likely to present with several co-morbidities in advanced stages, ELC for elderly patients with acute gallbladder disease is safe and effective, and should be regarded as the standard of care."
07/01/2006 - "In this review, we discuss the most important aspects of gallbladder disease and pregnancy as part of the Symposium on Liver and Pregnancy, co-sponsored by the Mexican Association of Hepatology and the Mexican Association of Gynecologists and Obstetrics."
09/01/1994 - "More than half the patients had at least one co-morbidity in addition to their gallbladder disease. "

02/01/1999 - "The prostanoid response of gallbladder cells stimulated by proinflammatory agents is inhibited by COX-2 inhibitors suggesting that these agents may be effective in treating the pain and inflammation of gallbladder disease."

09/01/1989 - "Cyclooxygenase inhibitors decrease gallbladder prostaglandin formation and are effective in producing relief of the symptoms of gallbladder disease. "

01/19/2005 - "Both trials showed greater risk of any gallbladder disease or surgery with estrogen (CEE: HR, 1.67; 95% CI, 1.35-2.06; E + P: HR, 1.59; 95% CI, 1.28-1.97). "
01/01/1988 - "Although an increase in the risk of gallbladder disease in women using supplemental estrogens has been consistently observed in previous studies, the risk after cessation of use has received little attention but could be important. "
04/01/1982 - " An increased risk of gallbladder disease may be associated with estrogen therapy, but this risk is minimal and has not been observed in all studies. "
01/19/2005 - "To determine the effect of estrogen therapy in healthy postmenopausal women on gallbladder disease outcomes. "
01/19/2005 - "Effect of estrogen therapy on gallbladder disease."

07/01/2007 - "Several studies suggest that oral menopausal hormone therapy (MHT) is associated with an increased risk of gallbladder disease. "
07/01/2007 - "Menopausal hormone therapy and gallbladder disease: the Study of Health in Pomerania (SHIP)."
06/01/1980 - "Part II. Clinical study: fluorescence histochemical studies in various gallbladder disease in human--especially on relationship between autonomic nerves, digestive tract hormones, EC-cells and mast cells (author's transl)]."
08/19/1998 - "Within the overall null effect, there was a statistically significant time trend, with more CHD events in the hormone group than in the placebo group in year 1 and fewer in years 4 and 5. More women in the hormone group than in the placebo group experienced venous thromboembolic events (34 vs 12; RH, 2.89; 95% CI, 1.50-5.58) and gallbladder disease (84 vs 62; RH, 1.38; 95% CI, 1.00-1.92). "
05/15/1950 - "[Adrenocortical hormone therapy of chronic gallbladder disease]."

05/17/2011 - "Oral contraceptives and the risk of gallbladder disease: a comparative safety study."
03/01/1986 - "Prior studies of the association between oral contraceptives (OCs) and gallbladder disease (GBD) have yielded conflicting results. "
09/20/2011 - "Oral contraceptives and risk of gallbladder disease."
01/01/2006 - "Oral contraceptives do not pose a greater risk for gallbladder disease. "
08/01/1994 - "It is concluded that it is unlikely that oral contraceptives are of either clinical or public health significance in relation to the occurrence of gallbladder disease."

08/01/1998 - "This study examined the correlates of clinical gallbladder disease among US adults and whether serum ascorbic acid levels are associated with a decreased prevalence of gallbladder disease. "
04/10/2000 - "Serum ascorbic acid level was inversely related to prevalence of clinical and asymptomatic gallbladder disease among women, but not among men. "
04/10/2000 - "Serum ascorbic acid and gallbladder disease prevalence among US adults: the Third National Health and Nutrition Examination Survey (NHANES III)."
08/01/1998 - "An inverted U-shaped relation was found between serum ascorbic acid level and clinical gallbladder disease among women but not among men. "
08/01/1998 - "Serum ascorbic acid and other correlates of gallbladder disease among US adults."

03/01/2009 - "Laparoscopic cholecystectomy is now indisputably the gold standard for managing most gallbladder diseases. "
09/01/2006 - "Laparoscopic cholecystectomy is the gold standard treatment for most gallbladder diseases. "
02/01/2003 - "Laparoscopic cholecystectomy (LC) is accepted as a "gold standard" for treating most gallbladder diseases because it is superior to the open method, causes less postoperative pulmonary dysfunction, and promotes earlier postoperative recovery. "
11/01/1994 - "Laparoscopic cholecystectomy is a major advance in the management of patients with symptomatic gall-bladder disease. "
05/01/1993 - "Laparoscopic cholecystectomy is a major advance in the management of patients with symptomatic gallbladder disease. "

10/01/1988 - "This compares well with patients undergoing cholecystectomy for uncomplicated calculous gallbladder disease, 88 per cent of whom, in our study, were improved by surgery. "
05/01/1986 - "The presence of bilirubinate sludge may predict symptomatic improvement in those patients with acalculous gallbladder disease undergoing cholecystectomy."
12/01/1984 - "Intraoperative ultrasonography shows promise in detecting nonpalpable gallbladder disease and decreasing the incidence of delayed cholecystectomy."
11/01/2015 - "Low rates of gallbladder disease following RYGB and high complication rates of concomitant cholecystectomy have been published, but these population-based studies have lacked long-term outcomes and survival data. "
06/01/2015 - "This study was conducted to describe the characteristics of pediatric patient who underwent cholecystectomy unrelated to hematologic disorders, and then to suggest its clinical significance in management by comparing a simple and complicated gallbladder disease. "

05/01/2000 - "To examine the role of estrogen replacement therapy on the development of gallbladder disease in postmenopausal women. "
05/01/2000 - "Estrogen replacement therapy and gallbladder disease in postmenopausal women."
09/01/1981 - "Studies have shown that side effects of estrogen replacement therapy include endometrial cancer, hypertension, gallbladder disease, and angina pectoris. "
02/01/1983 - " Complications of estrogen replacement include endometrial cancer, breast cancer, hypertension, hyperlipidemia, and gallbladder disease, the latter 3 apparently resulting from hepatic action of estrogen replacement therapy. "
04/01/1977 - "Contraindications to estrogen replacement include undiagnosed vaginal bleeding, breast cancer history of thromboembolic disease, liver disease, uterine leiomyomata, hypertension, diabetes, migraine headaches or gall bladder disease. "

09/01/2002 - "Thirteen patients with gallbladder disease underwent power Doppler ultrasound (PDUS) before and after microbubble contrast agent injection. "
04/01/1998 - "We evaluated the efficacy of contrast-enhanced ultrasonography (CEUS) with intra-arterial injection of CO2 microbubbles in 37 cases of gall bladder diseases. "
11/01/1994 - "Ultrasonographic (US) angiography was performed by sonographic examination with injection of carbon dioxide microbubbles through a catheter following conventional angiography in 41 patients with various gallbladder diseases. "

02/01/2005 - "Normal human gallbladder tissue samples from five individuals without any history of gallbladder disease were obtained through an organ donor transplantation program. "
08/01/2011 - "Endoscopic transpapillary gallbladder drainage for symptomatic gallbladder disease is a safe and effective bridge therapy in patients at high risk for surgery or who have terminal liver disease and are awaiting transplantation. "